PMID- 23282861
OWN - NLM
STAT- MEDLINE
DCOM- 20130213
LR  - 20220409
IS  - 1545-861X (Electronic)
IS  - 0149-2195 (Linking)
VI  - 61
IP  - 51-52
DP  - 2013 Jan 4
TI  - Cervical cancer screening among women aged 18-30 years - United States, 
      2000-2010.
PG  - 1038-42
AB  - Screening women for cervical cancer can save lives. However, among young women, 
      cervical cancer is relatively rare, and too-frequent screening can lead to high 
      costs and adverse events associated with overtreatment. Before 2012, cervical 
      cancer screening guidelines of the American College of Obstetricians and 
      Gynecologists (ACOG), American Cancer Society (ACS), and U.S. Preventive Services 
      Task Force (USPSTF) differed on age to start and how often to get screened for 
      cervical cancer. In 2012, however, all three organizations recommended that 1) 
      screening by Papanicolau (Pap) test should not be used for women aged <21 years, 
      regardless of initiation of sexual activity, and 2) a screening interval of 3 
      years should be maintained for women aged 21-30 years. ACS and ACOG explicitly 
      recommend against yearly screening. To assess trends in Pap testing before the 
      new guidelines were introduced, CDC analyzed 2000-2010 data from the Behavioral 
      Risk Factor Surveillance System (BRFSS) for women aged 18-30 years. CDC found 
      that, among women aged 18-21 years, the percentage reporting never having been 
      screened increased from 26.3% in 2000 to 47.5% in 2010, and the proportion 
      reporting having had a Pap test in the past 12 months decreased from 65.0% to 
      41.5%. Among those aged 22-30 years, the proportion reporting having had a Pap 
      test within the preceding 12 months decreased from 78.1% to 67.0%. These findings 
      showed that Pap testing practices for young women have been moving toward the 
      latest guidelines. However, the data also showed a concerning trend: among women 
      aged 22-30 years, who should be screened every 3 years, the proportion who 
      reported never having had a Pap test increased from 6.6% to 9.0%. More effort is 
      needed to promote acceptance of the latest evidence-based recommendations so that 
      all women receive the maximal benefits of cervical cancer screening.
CN  - Centers for Disease Control and Prevention (CDC)
LA  - eng
PT  - Journal Article
PL  - United States
TA  - MMWR Morb Mortal Wkly Rep
JT  - MMWR. Morbidity and mortality weekly report
JID - 7802429
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Behavioral Risk Factor Surveillance System
MH  - Early Detection of Cancer/*statistics & numerical data
MH  - Female
MH  - Guideline Adherence/statistics & numerical data
MH  - Humans
MH  - Practice Guidelines as Topic
MH  - Time Factors
MH  - United States/epidemiology
MH  - Uterine Cervical Neoplasms/*diagnosis
MH  - Vaginal Smears/*statistics & numerical data
MH  - Young Adult
EDAT- 2013/01/04 06:00
MHDA- 2013/02/14 06:00
CRDT- 2013/01/04 06:00
PHST- 2013/01/04 06:00 [entrez]
PHST- 2013/01/04 06:00 [pubmed]
PHST- 2013/02/14 06:00 [medline]
AID - mm6151a2 [pii]
PST - ppublish
SO  - MMWR Morb Mortal Wkly Rep. 2013 Jan 4;61(51-52):1038-42.